BSE filing, NSE: JAGSNPHARM. Summary written from the filing by ALFA Finder's alert engine.
Jagsonpal Pharmaceuticals Ltd: key numbers
- Share price
- ₹236.20
- Market cap
- ₹1,558 Cr
- Revenue (annual)
- ₹287.2 Cr
- Net profit (annual)
- ₹43.08 Cr
- P/E (TTM)
- 34.3×Sector 46.5×
- Promoter holding
- 68.81%-0.24% QoQ
- FII holding
- 2.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jagsonpal Pharmaceuticals Ltd
All →Jagsonpal Pharmaceuticals Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹964 Mn (+29%, Aequitas consolidated); standalone revenue ₹814 Mn (+9.3%), EBITDA margin 22.7%, PAT ₹126 Mn flat. H1 standalone PAT +10.3%.
Jagsonpal Pharmaceuticals Q2 FY27 Results: Net Profit ₹12.6 Cr, Up 0.0% YoY
Jagsonpal Pharmaceuticals Ltd reported revenue from operations of ₹81.4 Cr (+9.3% YoY) and net profit of ₹12.6 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹12.6 Cr · +0.0% YoY
Jagsonpal Pharmaceuticals Board Meeting Date
Jagsonpal Pharmaceuticals Ltd will hold a Board Meeting on October 28, 2026, to consider and approve the company's unaudited financial results for the quarter ended September 30, 2026.
Jagsonpal Pharmaceuticals Other Announcement
Jagsonpal Pharmaceuticals Ltd filed its quarterly shareholding pattern statement in compliance with SEBI Regulation 31(1)(b).
Jagsonpal Pharmaceuticals Acquisition
Jagsonpal Pharmaceuticals has completed the acquisition of the Wellness Portfolio from Group Pharmaceuticals Limited, following the fulfilment of all conditions precedent in the agreement.
- From
- Group Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Employee Stock Options
Jagsonpal Pharmaceuticals Limited allotted 101,825 equity shares upon the exercise of employee stock options. This issuance expands the company's paid-up share capital.
Other results update announcements
All →IIFL Capital Services Results Update
IIFL Capital Services reported consolidated Q2FY27 revenue of ₹722 crore, up 22% year-on-year, with PBT of ₹174 crore. The press release also covers the Fairfax change-in-control and a proposed NBFC subsidiary.
R R Kabel Results Update
R R Kabel's press release reports record half-year revenue, operating EBITDA and PAT for H1 FY27. Revenue rose 53% year-on-year, driven by wires and cables growth.
Gokul Agro Resources Results Update
Gokul Agro reported Q2FY27 revenue up 13% and PAT up 40% year on year. H1FY27 revenue rose 10%, with PAT up 54%.
Credent Connect N Care Results Update
Credent reported H1 FY27 consolidated revenue of ₹138.09 Crore (up 53.4%) and PAT of ₹14.65 Crore. It guides FY27 revenue of ₹320 Crore plus.
Pidilite Industries Results Update
Pidilite reported Q2 FY27 standalone net sales of Rs 3,982 crore, up 21.7%, with PAT up 10.4%. EBITDA margin was 20.4% after input cost headwinds.
Womancart Results Update
Womancart issued a Q2 and H1 FY27 press release reporting revenue and profit growth. Growth reflects an expanding product range and omnichannel presence.